AI assistant
10x Genomics, Inc. — Director's Dealing 2021
Jan 6, 2021
31830_dirs_2021-01-06_35a59e95-9d21-4cef-a8fa-a9a31a167ffc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-01-04
Reporting Person: Hindson Benjamin J. (Director, See Remarks, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-04 | Class A Common Stock | S | 3699 | $138.7796 | Disposed | 100437 | Direct |
| 2021-01-04 | Class A Common Stock | S | 22026 | $139.8263 | Disposed | 78411 | Direct |
| 2021-01-04 | Class A Common Stock | S | 6825 | $140.6219 | Disposed | 71586 | Direct |
| 2021-01-04 | Class A Common Stock | S | 1200 | $141.5804 | Disposed | 70386 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2: This transaction was executed in multiple trades at prices ranging from $138.265 to $139.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3: This transaction was executed in multiple trades at prices ranging from $139.27 to $140.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4: This transaction was executed in multiple trades at prices ranging from $140.28 to $141.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5: This transaction was executed in multiple trades at prices ranging from $141.315 to $142.07. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.